Levanase Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Biological Context

Levanase antibodies are immunochemical reagents specifically designed to detect and study levanase enzymes, which catalyze the hydrolysis of levan—a β-2,6-linked fructan polymer. These antibodies are critical tools in molecular biology for quantifying levanase expression, localizing the enzyme in cellular environments, and analyzing its functional interactions . Levanases are produced by microorganisms such as Bacillus spp., Actinomyces naeslundii, and Bacteroides thetaiotaomicron, and play roles in carbohydrate metabolism, biofilm formation, and industrial levan processing .

Research Applications and Methodologies

Levanase antibodies are employed in diverse experimental workflows:

ApplicationMethodExample
Enzyme LocalizationWestern Blotting, ELISADetection of cell-associated vs. secreted LsdB in A. naeslundii .
Activity AssaysSDS-PAGE with immunodetectionConfirming levanase activity post-electrophoresis using anti-levan antibodies .
Mutant Strain ValidationImmunoblottingVerifying extracellular levanase absence in lsdJ knockout strains .

Antibody-Driven Characterization of Levanase Variants

  • Extracellular Protease Effects: Deletion of extracellular protease genes in Bacillus amyloliquefaciens increased levanase stability, elevating levan production by 103% .

  • Signal Peptide Processing: Anti-LsdB antibodies confirmed the cleavage of a 36-residue signal peptide during secretion, critical for enzyme maturation .

Industrial and Biomedical Relevance

  • Prebiotic Synthesis: Engineered levanases (e.g., Y237S mutant in B. amyloliquefaciens) produce fructooligosaccharides (LFOS) with prebiotic properties, monitored via antibody-based quality control .

  • Therapeutic Potential: Anti-levanase antibodies aid in developing enzyme therapies for dental biofilms, targeting A. naeslundii levanase (LevJ) .

Future Directions

Advances in antibody engineering, such as single-chain variable fragments (scFvs), could enhance levanase detection sensitivity. Coupling these antibodies with CRISPR-based gene editing may further optimize microbial levanase production for biotechnological applications .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (12-14 weeks)
Synonyms
antibody; Levanase antibody; EC 3.2.1.65 antibody; 2,6-beta-D-fructan fructanohydrolase antibody; Endo-levanase antibody; Fragment antibody
Uniprot No.

Target Background

Function
Levanase is an enzyme that catalyzes the hydrolysis of levan with endo-type specificity. The products of levan hydrolysis include a mixture of fructose and a series of fructooligosaccharides up to 12-mer, with levantriose being the major oligosaccharide obtained. It is noteworthy that levanase does not exhibit activity towards sucrose.
Protein Families
Glycosyl hydrolase 32 family
Subcellular Location
Secreted.

Q&A

What is levanase and why are levanase antibodies important in polysaccharide research?

Levanase is an enzyme that hydrolyzes β-2,6-glycosidic bonds in levan, a fructose polysaccharide biopolymer produced by various microorganisms including Bacillus subtilis, Lactobacillus spp., and Actinomyces naeslundii . The enzyme specifically targets high molecular weight levan molecules, breaking them down into oligosaccharides with low degrees of polymerization (1-10 kDa), including levanotriosis, levanobiosis, and to a small extent, fructose molecules .

Levanase antibodies are crucial research tools that allow for the detection, localization, and characterization of levanase enzymes or their products in experimental systems. These antibodies enable researchers to track levan metabolism, study enzymatic activity, and investigate the roles of specific genes in levan production and degradation pathways . With the growing interest in microbial polysaccharides for applications in food production, medicine, and biotechnology, levanase antibodies have become essential components in advancing our understanding of these complex carbohydrate systems.

How does levanase differ from levansucrase in polysaccharide metabolism?

While both enzymes participate in levan metabolism, they serve distinct functional roles:

Levanase, encoded by genes such as levB in Bacillus subtilis or levJ in Actinomyces naeslundii, acts primarily as an endo-levanase . It hydrolyzes β-2,6-glycosidic bonds within the levan polymer, producing smaller oligosaccharides but notably does not disrupt β-2,1 bonds at branching points . The enzyme typically remains bound to the cell membrane and targets high molecular weight levan molecules.

Research has shown that these enzymes can work synergistically; levanase's endo-activity stimulates the exo-levanase function of levansucrase, resulting in enhanced fructose release . This cooperative activity mimics the action of the sacC gene product on levan, demonstrating the complexity of polysaccharide metabolism systems.

What are the primary techniques for detecting levan using antibodies?

Several antibody-based techniques have been developed for detecting levan in research settings:

The most common approach involves using specific anti-levan monoclonal antibodies, such as UPC-10 . In one documented protocol, researchers incubate membrane filters overnight at 37°C in 50 mM sucrose, briefly rinse them in TBS (Tris-buffered saline), and then incubate with the UPC-10 antibody to detect levan formation .

For protein-associated levan activity, researchers have developed a sensitive technique to detect levan formation by proteins separated via sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) . This method allows visualization of levan-synthesizing activity directly within a gel system, enabling researchers to identify specific proteins responsible for levan production.

Additionally, enzyme-linked immunosorbent assay (ELISA)-based methods have been employed to detect levan synthesis, particularly in bacterial culture systems grown with or without sucrose supplementation . These approaches allow for quantitative assessment of levan production under varying experimental conditions.

How can researchers distinguish between different forms of levanase activity in complex microbial systems?

Distinguishing between different levanase activities in complex microbial systems requires a multi-faceted approach:

  • Genetic characterization: PCR amplification of levanase gene homologues using primers designed from known sequences (e.g., from Actinomyces naeslundii strain T14V) can identify potential levanase-encoding genes . Subsequent sequencing confirms homology to known levanase genes. For instance, researchers amplified a 0.5-kbp internal fragment of the levanase gene from A. naeslundii WVU45 using primers based on the known sequence of the levJ gene .

  • Enzyme activity profiling: Different levanase enzymes display varying kinetic parameters, substrate preferences, and product profiles. Researchers can analyze hydrolysis products using techniques like high-performance liquid chromatography (HPLC) to characterize the specific action patterns of different levanases. For example, the levanase encoded by levB specifically produces oligosaccharides down to levanotriosis and levanobiosis .

  • Antibody-based differentiation: Developing and using antibodies with specificity for different levanase variants can help identify and track specific enzyme forms in mixed cultures or environmental samples. Monoclonal antibodies can be particularly useful for distinguishing closely related enzyme variants.

  • Gene knockout studies: Creating mutant strains with insertions or deletions in specific levanase genes allows researchers to attribute observed enzymatic activities to particular genetic loci. This approach was demonstrated in studies where researchers created levanase-deficient mutants of A. naeslundii WVU45 by targeting the levJ gene .

  • Subcellular localization: Different levanase enzymes may be localized to different cellular compartments. Some remain bound to the cell membrane, while others may be secreted into the extracellular environment. Fractionation studies combined with antibody detection can help distinguish these different forms.

What are the challenges in developing specific antibodies against different domains of the levanase enzyme?

Developing specific antibodies against different domains of levanase enzymes presents several significant challenges:

  • Structural complexity: Levanase enzymes contain multiple functional domains with varying degrees of conservation across species. The catalytic domains may share high sequence similarity with other glycoside hydrolases, making it difficult to generate antibodies that specifically recognize levanase without cross-reactivity .

  • Protein purification hurdles: Obtaining pure, correctly folded levanase for immunization can be challenging. Researchers often need to express recombinant proteins, as demonstrated in the studies where His-tagged FTF (a related enzyme) was purified using denaturing protocols followed by preparative SDS-PAGE . The denaturation process may alter epitope presentation, potentially reducing antibody specificity for the native enzyme.

  • Cross-reactivity with related enzymes: Levanase belongs to a family of structurally similar enzymes, including other fructan-active enzymes. Antibodies raised against levanase might cross-react with related proteins like inulinase or sucrase, necessitating extensive validation to confirm specificity.

  • Domain-specific targeting: Generating antibodies that specifically recognize functional domains (e.g., catalytic domain versus carbohydrate-binding module) requires careful epitope selection and validation. Researchers must identify unique, surface-exposed regions within each domain that are not conserved in other proteins.

  • Conformational epitopes: Many enzymatic domains maintain specific three-dimensional structures critical for function. Antibodies recognizing these conformational epitopes may not bind to denatured proteins in Western blots but may work well in native applications like immunoprecipitation or activity inhibition assays.

  • Species variation: Levanase enzymes from different bacterial species show significant sequence variation. For example, the levanase from A. naeslundii WVU45 showed only 92% sequence identity to that from A. naeslundii T14V . Antibodies developed against one species' levanase may not recognize orthologs from other species.

How do genetic and environmental factors influence the expression and detection of levanase in microbial systems?

Genetic and environmental factors substantially impact levanase expression and detection in microbial systems:

Genetic factors:

  • Operon structure and regulation: Levanase genes are often organized in operons with complex regulatory mechanisms. In Bacillus subtilis, for example, the levanase operon is distinct from the levansucrase gene but works cooperatively with it . Understanding these genetic organizations is crucial for predicting expression patterns.

  • Gene homology and variation: Different microbial species possess varying forms of levanase genes. The levanase gene from A. naeslundii WVU45 showed 92% sequence identity to that from strain T14V at the amino acid level . This variation affects both expression patterns and antibody recognition.

  • Promoter elements: The presence of specific promoter elements influences levanase expression in response to environmental cues. Identifying these regulatory sequences helps predict conditions under which levanase will be expressed.

Environmental factors:

  • Carbon source availability: Levanase expression is often regulated by carbon source availability. Many bacteria show differential expression when grown in media containing different carbohydrates like glucose, sucrose, or fructose . For example, A. naeslundii was grown in a semidefined medium containing 1% glucose, sucrose, or fructose as the carbohydrate source to study levanase expression .

  • Growth phase dependence: Expression of levanase often varies with bacterial growth phase, with some species showing higher expression during exponential growth while others demonstrate increased expression during stationary phase.

  • Culture conditions: Temperature, pH, oxygen availability, and media composition significantly influence levanase expression levels. Optimizing detection protocols requires consideration of these variables.

Experimental considerations for detection:

  • Sample preparation: Different extraction methods may yield varying results in levanase detection. Cell disruption techniques, buffer compositions, and fractionation approaches all influence the recovery of active enzyme.

  • Antibody selection: The choice of antibody (polyclonal vs. monoclonal, raised against whole protein vs. specific domains) dramatically affects detection sensitivity and specificity .

  • Detection method compatibility: Some detection methods may be incompatible with certain sample types or experimental conditions. For instance, fluorescence-based assays may suffer from interference in complex biological samples.

What are the most effective protocols for detecting levanase activity using antibody-based techniques?

The most effective protocols for detecting levanase activity using antibody-based techniques incorporate multiple approaches tailored to specific research questions:

Immunoblot detection protocol:

  • Sample preparation: Harvest bacterial cultures (e.g., A. naeslundii) grown in appropriate media (BHI or defined media with relevant carbon sources) . Separate cells from supernatant by centrifugation.

  • Protein separation: Perform SDS-PAGE to separate proteins based on molecular weight. Ensure proper sample loading (typically 10-20 μg protein per lane) and run appropriate molecular weight markers.

  • Transfer: Transfer proteins to a nitrocellulose or PVDF membrane using standard Western blot protocols.

  • Blocking: Block non-specific binding sites with 5% non-fat dry milk or BSA in TBS.

  • Primary antibody incubation: Incubate membrane with anti-levanase antibody (e.g., polyclonal rabbit sera against purified levanase) at appropriate dilution (typically 1:1000 to 1:5000) .

  • Secondary antibody: Apply species-appropriate HRP-conjugated secondary antibody.

  • Detection: Visualize using chemiluminescence or colorimetric detection systems.

In-gel levan formation assay:

This sensitive technique detects levan formation by proteins separated by SDS-PAGE :

  • After electrophoresis, wash the gel to remove SDS and renature proteins.

  • Incubate gel in buffer containing sucrose (typically 50 mM) at 37°C overnight.

  • Transfer formed levan to a membrane.

  • Detect levan using anti-levan monoclonal antibody UPC-10 .

  • Visualize using appropriate secondary antibody and detection system.

ELISA-based detection:

  • Coat plates with samples potentially containing levanase.

  • Block non-specific binding sites.

  • Add substrate solution containing sucrose.

  • After incubation period, detect formed levan using anti-levan antibody.

  • Apply secondary antibody conjugated with detection enzyme.

  • Add chromogenic substrate and measure absorbance.

These protocols have been successfully employed to confirm levan-synthesizing activity in different cellular fractions and to validate the phenotypes of genetic mutants like the ftf mutant of A. naeslundii, which was shown to be unable to produce levans .

How can researchers optimize antibody production against levanase for improved specificity and sensitivity?

Optimizing antibody production against levanase requires careful consideration of multiple factors to achieve high specificity and sensitivity:

Antigen selection and preparation:

  • Recombinant protein expression: Express levanase or specific domains as recombinant proteins with affinity tags for purification. Research has demonstrated success using His-tagged constructs in E. coli expression systems like M15 . Design constructs to exclude signal sequences that might interfere with proper folding.

  • Purification strategy: Implement multi-step purification protocols. For example, researchers have used denaturing protocols with Ni-NTA chromatography followed by preparative SDS-PAGE to obtain highly purified His-tagged proteins (>1.4 mg) .

  • Native vs. denatured antigens: Consider using both native and denatured protein preparations for immunization to generate antibodies recognizing different epitopes. Native proteins maintain conformational epitopes important for detecting the functional enzyme.

  • Peptide-based approach: For domain-specific antibodies, design synthetic peptides corresponding to unique, surface-exposed regions of levanase. Conjugate these peptides to carrier proteins like KLH or BSA to enhance immunogenicity.

Immunization and antibody production:

  • Host selection: Choose appropriate host animals based on the research needs. Rabbits are commonly used for polyclonal antibodies (as seen in the described research ), while mice or rats are preferred for monoclonal antibody development.

  • Immunization schedule: Implement a robust immunization protocol with proper adjuvant selection. Primary immunization followed by multiple boosters at 2-4 week intervals typically yields optimal responses.

  • Adjuvant selection: Complete Freund's adjuvant for primary immunization followed by incomplete Freund's for boosters has proven effective, though newer, less inflammatory adjuvants may be considered.

Antibody purification and validation:

  • Affinity purification: Purify antibodies using affinity chromatography with immobilized levanase to remove non-specific antibodies.

  • Cross-adsorption: Remove cross-reactive antibodies by adsorption against related proteins like other glycoside hydrolases.

  • Validation tests: Confirm specificity through multiple assays:

    • Western blot against recombinant levanase and whole cell lysates

    • Immunoprecipitation followed by activity assays

    • Immunohistochemistry with appropriate controls

    • ELISA to determine titer and cross-reactivity

  • Functional testing: Verify that antibodies detect enzymatically active levanase using activity-based assays like the in-gel levan formation test described in the research .

By following these optimization steps, researchers can develop highly specific and sensitive antibodies against levanase that are suitable for various applications in microbial polysaccharide research.

What genetic manipulation techniques are most effective for studying levanase expression and function?

Several genetic manipulation techniques have proven particularly effective for studying levanase expression and function:

Gene disruption and knockout strategies:

  • Insertional mutagenesis: This approach has been successfully used to create levanase-deficient mutants. For example, researchers created an A. naeslundii levanase mutant by amplifying a 0.5-kbp internal fragment of the levJ gene, cloning it into a suicide vector with a kanamycin resistance marker, and disrupting the chromosomal gene through Campbell-type insertion .

  • Double-crossover recombination: For complete gene replacement or deletion, researchers have employed double-crossover recombination. This was demonstrated with the ftf gene in A. naeslundii, where a kanamycin resistance determinant was inserted into the ftf gene between 1.2 kbp upstream and 0.8 kbp downstream flanking regions .

  • CRISPR-Cas9 systems: While not explicitly mentioned in the provided research, CRISPR-Cas9 technology offers precise genome editing capabilities for studying levanase, particularly in organisms where traditional homologous recombination is challenging.

Expression systems and promoter analysis:

  • Heterologous expression: Expressing levanase genes in model organisms facilitates functional characterization. The research shows successful expression of His-tagged FTF in E. coli M15, induced with IPTG at 1 mM concentration .

  • Promoter fusions: Creating fusions between levanase promoters and reporter genes (like GFP, luciferase, or lacZ) enables detailed analysis of expression patterns under different conditions.

  • Inducible expression systems: Using controllable promoters allows for temporal regulation of levanase expression, facilitating studies of enzyme function without interference from endogenous regulations.

Genetic complementation and site-directed mutagenesis:

  • Complementation analysis: Reintroducing functional levanase genes into mutant strains confirms phenotype attribution to specific genetic elements.

  • Site-directed mutagenesis: Creating precise mutations in catalytic or regulatory domains helps identify critical amino acids for levanase function.

  • Domain swapping: Exchanging domains between levanase and related enzymes provides insights into structure-function relationships.

PCR-based techniques for gene identification:

  • PCR amplification of homologous genes: Using primers designed from known levanase sequences has successfully identified levanase genes in different organisms. Researchers amplified the levJ gene from A. naeslundii WVU45 using primers based on the sequence from strain T14V .

  • Quantitative PCR: qPCR methods allow quantification of levanase gene expression levels under different conditions.

  • Genome walking: This technique helps identify flanking regulatory regions of levanase genes that influence expression patterns.

These methodologies have significantly advanced our understanding of levanase biology, allowing researchers to characterize both the enzymes and their regulatory elements across different microbial species.

How are levanase antibodies utilized in studying microbial polysaccharide metabolism?

Levanase antibodies serve multiple critical functions in the study of microbial polysaccharide metabolism:

Enzyme localization and distribution studies:

Antibodies enable precise localization of levanase enzymes within microbial cells and communities. Using immunofluorescence microscopy with specific anti-levanase antibodies, researchers can determine whether the enzyme is membrane-bound, cytoplasmic, or secreted into the extracellular environment. This information provides critical insights into the enzyme's biological role and the spatial organization of polysaccharide metabolism . The research indicates that levanase encoded by levB remains bound to the cell membrane, which has implications for its functional interactions with substrates and other enzymes .

Tracking enzyme expression:

Antibodies allow researchers to monitor levanase expression under various environmental conditions, providing insights into regulatory mechanisms. Western blot analysis using anti-levanase antibodies can quantify enzyme levels in response to different carbon sources, growth phases, or stress conditions. The studies revealed that expression patterns vary significantly depending on the carbon source (glucose, sucrose, or fructose) in the growth medium .

Validation of genetic manipulations:

Levanase antibodies provide essential tools for confirming the success of genetic modifications. For example, researchers used antibody detection to verify that ftf mutants of A. naeslundii were unable to produce levans, validating the role of this gene in levan synthesis .

Analysis of enzymatic complexes:

Through co-immunoprecipitation with anti-levanase antibodies, researchers can identify protein-protein interactions involved in polysaccharide metabolism. This approach has revealed that levanase may function in multi-enzyme complexes, particularly at the cell surface, facilitating efficient polysaccharide processing.

Functional studies:

Antibodies that recognize specific domains of levanase can be used to probe structure-function relationships. By targeting antibodies to catalytic or substrate-binding domains, researchers can assess how these regions contribute to enzyme activity and substrate specificity.

Development of diagnostic tools:

Levanase antibodies serve as components in diagnostic assays for detecting levan-producing microorganisms in environmental or clinical samples. The sensitive technique developed to detect levan formation after SDS-PAGE separation demonstrates this diagnostic potential .

These diverse applications of levanase antibodies have significantly advanced our understanding of microbial polysaccharide metabolism, providing insights that extend beyond basic enzyme characterization to ecological and clinical implications.

What are the experimental considerations when comparing levanase activity across different microbial species?

When comparing levanase activity across different microbial species, researchers must account for numerous experimental variables to ensure valid comparisons:

Standardization of growth conditions:

  • Media composition: Different species have varying nutritional requirements and regulatory mechanisms. Researchers should either use species-specific optimal media or a standardized medium that supports adequate growth of all species being compared. Studies have utilized both rich media (BHI) and defined media (ADM) with specified carbon sources (1% glucose, sucrose, or fructose) .

  • Growth phase sampling: Harvest cells at equivalent growth phases rather than at fixed time points, as levanase expression often varies throughout the growth cycle. Monitor growth curves for each species to determine appropriate sampling points.

  • Environmental parameters: Maintain consistent temperature, pH, aeration, and incubation times across all cultures. Document any species-specific deviations required for viable growth.

Enzyme extraction and handling:

  • Cell disruption methods: Different species vary in cell wall composition and resistance to lysis. Optimize extraction protocols for each species to ensure comparable enzyme recovery. Document extraction efficiency by measuring total protein recovery.

  • Subcellular fractionation: Separate cell fractions (membrane, cytoplasmic, extracellular) consistently across species, as levanase localization may differ. The research notes that levanase encoded by levB remains bound to the cell membrane in B. subtilis , while other species may have different localization patterns.

  • Buffer compatibility: Ensure extraction and assay buffers maintain enzyme stability across all species. Test multiple buffer systems if necessary.

Activity measurement standardization:

  • Substrate considerations: Use consistent substrate preparations for activity assays. Levan source, molecular weight, and branching patterns can significantly impact measured activity. Consider using both natural and synthetic substrates for comprehensive comparison.

  • Assay conditions: Standardize temperature, pH, ion concentrations, and reaction times. If species show different pH or temperature optima, perform assays under multiple conditions.

  • Detection methods: Apply consistent detection techniques across all samples. The described in-gel levan formation assay and antibody-based detection methods should be validated for each species .

Genetic and evolutionary considerations:

  • Gene homology assessment: Compare levanase gene sequences across species to establish evolutionary relationships. Percent identity analyses (as shown with the 92% identity between A. naeslundii strains ) help contextualize functional differences.

  • Isoenzyme identification: Many species possess multiple levanase isoforms with distinct properties. Characterize all relevant isoenzymes before making species-level comparisons.

  • Codon optimization: When using recombinant expression systems, account for codon bias differences between species that might affect heterologous expression levels.

By systematically addressing these experimental considerations, researchers can generate meaningful comparisons of levanase activity across diverse microbial species, providing insights into evolutionary adaptations and ecological significance of this important enzyme system.

How can levanase antibodies be integrated with other research techniques for comprehensive analysis of polysaccharide metabolism?

Integrating levanase antibodies with complementary research techniques creates powerful experimental frameworks for comprehensive analysis of polysaccharide metabolism:

Combined genomic and immunological approaches:

  • Genomics-guided antibody development: Sequence analysis of multiple levanase genes identifies conserved and variable regions, enabling development of pan-specific and species-specific antibodies. Researchers have used PCR to amplify levanase gene homologues based on known sequences, followed by antibody production against the encoded proteins .

  • ChIP-seq analysis: Chromatin immunoprecipitation using antibodies against transcription factors that regulate levanase genes, combined with sequencing, reveals global regulatory networks controlling polysaccharide metabolism.

  • Ribosome profiling with immunoprecipitation: This combination can correlate translational activity with protein production for levanase and related enzymes.

Integrated microscopy techniques:

  • Correlative light and electron microscopy (CLEM): Using fluorescently-labeled antibodies for light microscopy followed by electron microscopy of the same sample provides both spatial enzyme distribution and ultrastructural context.

  • Super-resolution microscopy: Techniques like STORM or PALM with levanase antibodies can reveal nanoscale organization of enzymes relative to cell structures and other metabolic components.

  • Live-cell imaging: Combining antibody fragments (Fab) labeled with fluorescent tags enables tracking of levanase dynamics in living cells.

Multi-omics integration:

  • Proteomics with immunoenrichment: Immunoprecipitation using levanase antibodies followed by mass spectrometry identifies interaction partners and post-translational modifications affecting enzyme function.

  • Metabolomics correlation: Linking antibody-detected enzyme levels with metabolite profiles through statistical approaches reveals functional consequences of levanase activity.

  • Transcriptomics validation: Correlating mRNA expression data with antibody-detected protein levels highlights post-transcriptional regulation mechanisms.

Functional assays with antibody applications:

  • Enzymatic inhibition studies: Using antibodies that block specific domains of levanase to assess domain contributions to catalytic activity. This approach complements genetic studies where researchers created levanase-deficient mutants .

  • Biofilm analysis: Combining anti-levan antibodies (like UPC-10) with biofilm staining techniques reveals the spatial distribution of levan within microbial communities .

  • Flow cytometry: Using fluorescently labeled anti-levanase antibodies for quantitative analysis of enzyme expression at the single-cell level, revealing population heterogeneity.

In vivo applications:

  • Intravital microscopy: Applying labeled antibody fragments to visualize levanase activity in model organisms colonized with levan-producing bacteria.

  • Immunohistochemistry of host tissues: Detecting levan deposition in host tissues using anti-levan antibodies provides insights into host-microbe interactions.

  • Antibody-based biosensors: Developing field-deployable biosensors using levanase antibodies for environmental monitoring of polysaccharide-producing microorganisms.

By strategically integrating these multidisciplinary approaches with levanase antibodies, researchers can achieve unprecedented insights into polysaccharide metabolism across scales ranging from molecular interactions to ecological dynamics.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.